A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Clinical trial NCT02041091 · TERMINATED

Trial details

NCT number: NCT02041091
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2014-01-01
Primary completion: 2014-10-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.